Valproic acid attenuates hyperglycemia-induced complement and coagulation cascade gene expression

No abstract is available for this paper.

• Publication year

  2018

• Venue

  bioRxiv

• Publication date

  2018-01-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1101/253591
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Sequence Analysis

  2020cited by this paper
• Repurposing Valproate, Enteral Clonidine, and Phenobarbital for Comfort in Adult ICU Patients: A Literature Review with Practical Considerations

  2017cited by this paper
• Systems approach to the pharmacological actions of HDAC inhibitors reveals EP300 activities and convergent mechanisms of regulation in diabetes

  2017cited by this paper
• Multicellular Transcriptional Analysis of Mammalian Heart Regeneration

  2017cited by this paper
• A pathogenic role of complement in arterial hypertension and hypertensive end organ damage.

  2017cited by this paper
• Repurposing the anti-epileptic drug sodium valproate as an adjuvant treatment for diffuse intrinsic pontine glioma

  2017cited by this paper
• The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation

  2016cited by this paper
• Differential Response of Human Hepatocyte Chromatin to HDAC Inhibitors as a Function of Microenvironmental Glucose Level

  2016cited by this paper
• The role of complement system in adipose tissue-related inflammation

  2016cited by this paper
• Fibrinolysis and the control of blood coagulation.

  2015cited by this paper
• Plos One

  2015cited by this paper
• Plasma levels of mannan‐binding lectin‐associated serine proteases MASP‐1 and MASP‐2 are elevated in type 1 diabetes and correlate with glycaemic control

  2015cited by this paper
• HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes

  2015cited by this paper
• Histone deacetylase 3 inhibition improves glycaemia and insulin secretion in obese diabetic rats

  2015cited by this paper
• Reincarnation of ancient links between coagulation and complement

  2015cited by this paper
• Valproate attenuates the proteinuria, podocyte and renal injury by facilitating autophagy and inactivation of NF-κB/iNOS signaling in diabetic rat.

  2015cited by this paper
• Cardioprotective effects of magnesium valproate in type 2 diabetes mellitus.

  2014cited by this paper
• Mannan-Binding Lectin in Cardiovascular Disease

  2014cited by this paper
• Vascular histone deacetylation by pharmacological HDAC inhibition

  2014cited by this paper
• Valproic Acid Is a Novel Activator of AMP-Activated Protein Kinase and Decreases Liver Mass, Hepatic Fat Accumulation, and Serum Glucose in Obese Mice

  2014cited by this paper
• The role of the complement system in metabolic organs and metabolic diseases.

  2013cited by this paper
• Hepatocyte Nuclear Factor 4 Alpha and Farnesoid X Receptor Co-regulates Gene Transcription in Mouse Livers on a Genome-Wide Scale

  2013cited by this paper
• featureCounts: an efficient general purpose program for assigning sequence reads to genomic features

  2013cited by this paper
• RNA-sequencing analysis of high glucose-treated monocytes reveals novel transcriptome signatures and associated epigenetic profiles.

  2013cited by this paper
• Complement‐mediated chronic inflammation is associated with diabetic microvascular complication

  2013cited by this paper
• Discovering new treatments for Alzheimer's disease by repurposing approved medications.

  2013cited by this paper
• Complement in Immune and Inflammatory Disorders: Therapeutic Interventions

  2013cited by this paper
• Transcriptional regulators of hepatic gluconeogenesis

  2013cited by this paper
• Complement inhibition in cancer therapy.

  2013cited by this paper
• Epigenetic changes in diabetes

  2013cited by this paper
• Factor XIII, clot structure, thrombosis.

  2012cited by this paper
• Genes Are Often Sheltered from the Global Histone Hyperacetylation Induced by HDAC Inhibitors

  2012cited by this paper
• Diabetes mellitus and thrombosis.

  2012cited by this paper
• Chromatin Modifications Associated with Diabetes

  2012cited by this paper
• Up-regulation of the complement system in subcutaneous adipocytes from nonobese, hypertriglyceridemic subjects is associated with adipocyte insulin resistance.

  2012cited by this paper
• A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3

  2012cited by this paper
• Complement C3 is a novel plasma clot component with anti-fibrinolytic properties

  2012cited by this paper
• Transcription factors and coactivators controlling nutrient and hormonal regulation of hepatic gluconeogenesis.

  2012cited by this paper
• Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis.

  2011cited by this paper
• Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells.

  2011cited by this paper
• Molecular signatures database (MSigDB) 3.0

  2011cited by this paper
• The role of class I histone deacetylase (HDAC) on gluconeogenesis in liver.

  2011cited by this paper
• Histone Deacetylase (HDAC) Inhibition as a Novel Treatment for Diabetes Mellitus

  2011cited by this paper
• Inflammation and thrombosis in diabetes

  2011cited by this paper
• Hyperglycemia: a prothrombotic factor?

  2010cited by this paper
• Molecular Intercommunication between the Complement and Coagulation Systems

  2010cited by this paper
• Hemostatic abnormalities in endocrine and metabolic disorders.

  2010cited by this paper
• edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

  2009cited by this paper
• Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk: A Population Study of 3.3 Million People

  2008cited by this paper
• Complement-targeted therapeutics

  2007cited by this paper
• Complement and coagulation: strangers or partners in crime?

  2007cited by this paper
• The complement system in liver diseases.

  2006cited by this paper
• Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study.

  2004cited by this paper
• Theoretical and practical advances in genome halving

  2004cited by this paper
• Consistent lowering of clotting factors for the treatment of acute cardiovascular syndromes and hypercoagulability: a different pathophysiological approach.

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Mechanism by which metformin reduces glucose production in type 2 diabetes.

  2000cited by this paper
• Mechanism on Disorders of Coagulation and Fibrinolysis in Diabetes

  1996cited by this paper
• The teaching of social and community medicine. Letting students do the work: an aspect of audiovisual aids to teaching.

  1970cited by this paper

• mitch: multi-contrast pathway enrichment for multi-omics and single-cell profiling data

  2020cites this paper